Anavex Life Sciences (AVXL) News Today $6.74 -0.10 (-1.46%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 24 at 1:13 PM | americanbankingnews.comAnavex Life Sciences (NASDAQ:AVXL) Stock Rating Upgraded by EF Hutton Acquisition Co. IJuly 24 at 10:20 AM | americanbankingnews.comAnavex Life Sciences (NASDAQ:AVXL) Rating Increased to Strong-Buy at EF Hutton Acquisition Co. IJuly 24 at 9:43 AM | americanbankingnews.comAnavex Life Sciences (NASDAQ:AVXL) Lifted to Strong-Buy at EF Hutton Acquisition Co. IJuly 23 at 7:08 PM | msn.comEF Hutton Initiates Coverage of Anavex Life Sciences (AVXL) with Buy RecommendationJuly 23 at 1:24 PM | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Shares Up 8.5%Anavex Life Sciences (NASDAQ:AVXL) Trading 8.5% HigherJuly 22, 2024 | markets.businessinsider.comBuy Rating on Anavex: Promising Clinical Results and Strong Financial StandingJuly 22, 2024 | marketbeat.comJupiter Asset Management Ltd. Buys 700,812 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)Jupiter Asset Management Ltd. lifted its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 675.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 804,642 shares of the biotechnologJuly 22, 2024 | msn.comCassava Alzheimer’s drug set for first Phase 3 readout by December 2024July 20, 2024 | americanbankingnews.comReviewing Apogee Therapeutics (NASDAQ:APGE) and Anavex Life Sciences (NASDAQ:AVXL)July 16, 2024 | americanbankingnews.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Short Interest Down 14.9% in JuneJuly 14, 2024 | marketbeat.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Short Interest UpdateAnavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 17,830,000 shares, a decline of 14.9% from the June 15th total of 20,940,000 shares. Based on an average daily volume of 1,160,000 shares, the days-to-cover ratio is currently 15.4 days.July 11, 2024 | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Stock Passes Above 50 Day Moving Average of $4.07Anavex Life Sciences (NASDAQ:AVXL) Share Price Crosses Above 50-Day Moving Average of $4.07June 20, 2024 | globenewswire.comAnavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceJune 18, 2024 | insidertrades.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Director Peter D.O. Donhauser Buys 2,835 SharesJune 17, 2024 | marketbeat.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Director Peter D.O. Donhauser Purchases 2,835 SharesAnavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) Director Peter D.O. Donhauser purchased 2,835 shares of the stock in a transaction that occurred on Friday, June 14th. The shares were acquired at an average cost of $3.64 per share, with a total value of $10,319.40. Following the completion of the transaction, the director now owns 5,000 shares in the company, valued at $18,200. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.May 22, 2024 | finance.yahoo.comSector Update: Health Care Stocks Slightly Higher Late AfternoonMay 22, 2024 | globenewswire.comAnavex Life Sciences Announces Expansion of Leadership TeamMay 21, 2024 | finance.yahoo.comAnavex Life Sciences (NASDAQ:AVXL) Is In A Good Position To Deliver On Growth PlansMay 18, 2024 | insidertrades.comSteffen Thomas Acquires 5,000 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) StockMay 17, 2024 | marketbeat.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Director Steffen Thomas Purchases 5,000 SharesAnavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) Director Steffen Thomas purchased 5,000 shares of the business's stock in a transaction on Wednesday, May 15th. The stock was purchased at an average price of $4.52 per share, with a total value of $22,600.00. Following the purchase, the director now owns 5,000 shares of the company's stock, valued at $22,600. The purchase was disclosed in a legal filing with the SEC, which is available through this link.May 14, 2024 | globenewswire.comAnavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQMay 13, 2024 | prnewswire.comShareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreMay 10, 2024 | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Releases Earnings Results, Hits EstimatesAnavex Life Sciences (NASDAQ:AVXL - Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.13). During the same period in the prior year, the firm posted ($0.17) EPS.May 10, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL)May 10, 2024 | finance.yahoo.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL)HC Wainwright reissued a "buy" rating and issued a $40.00 price objective on shares of Anavex Life Sciences in a research note on Friday.May 10, 2024 | prnewswire.comShareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreMay 9, 2024 | markets.businessinsider.comBuy Rating on Anavex Life Sciences Amid Promising Alzheimer’s Drug ProspectsMay 9, 2024 | markets.businessinsider.comAVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q2 2024May 9, 2024 | uk.finance.yahoo.comAnavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateMay 9, 2024 | finanznachrichten.deAnavex Life Sciences Corp.: Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateMay 9, 2024 | globenewswire.comAnavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateMay 8, 2024 | prnewswire.comBERGER MONTAGUE PC ANNOUNCES THE FILING OF A CLASS ACTION COMPLAINT TO RECOVER LOSSES FOR INVESTORS WHO PURCHASED ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL)May 8, 2024 | prnewswire.comLevi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - AVXLMay 7, 2024 | prnewswire.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the FirmMay 7, 2024 | prnewswire.comThe Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) ShareholdersMay 6, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitMay 6, 2024 | prnewswire.comShareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreMay 5, 2024 | stockhouse.comIMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit!May 5, 2024 | markets.businessinsider.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesMay 5, 2024 | markets.businessinsider.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesMay 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AnavexMay 3, 2024 | prnewswire.comAnavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXLMay 2, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitMay 2, 2024 | markets.businessinsider.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesMay 2, 2024 | globenewswire.comAnavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024May 1, 2024 | prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Corporation Lawsuit - AVXLApril 29, 2024 | prnewswire.comAVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud LawsuitApril 28, 2024 | markets.businessinsider.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex Life SciencesApril 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXL Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! AVXL Media Mentions By Week AVXL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVXL News Sentiment▼0.700.62▲Average Medical News Sentiment AVXL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVXL Articles This Week▼113▲AVXL Articles Average Week Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AMPH News ZLAB News KURA News NAMS News EVO News AVDL News SANA News RCUS News ARDX News DAWN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVXL) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
